CVE-2017-17678

Description

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

Category

6.1
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.42%
Vendor Advisory bmc.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://bmc.com product
http://remedy.com product
https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html release notes vendor advisory
https://seclists.org/fulldisclosure/2017/Oct/52 third party advisory mailing list

Frequently Asked Questions

What is the severity of CVE-2017-17678?
CVE-2017-17678 has been scored as a medium severity vulnerability.
How to fix CVE-2017-17678?
To fix CVE-2017-17678, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-17678 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-17678 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.